Related Experiment Videos

Inhibition of IFN regulatory factor-1 down-regulate Th1 cell function in patients with acute coronary syndrome

Min Guo1, Xiaobo Mao, Qingwei Ji

  • 1Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Journal of Clinical Immunology
|February 24, 2010
PubMed

Insights

Interferon regulatory factor-1 (IRF-1) promotes Th1 cell function in acute coronary syndrome (ACS). Inhibiting IRF-1 in CD4+ T cells reduces Th1 cell activity, suggesting IRF-1 as a potential therapeutic target in ACS.

Area of Science:

  • Immunology
  • Cardiovascular Disease
  • Molecular Biology

Background:

  • T helper (Th) cells and chronic inflammation are key in atherosclerosis and coronary artery disease.
  • Th cell type 1 (Th1) is implicated in acute coronary syndrome (ACS) pathogenesis.
  • Mechanisms of Th1 cell generation in ACS remain unclear; IFN regulatory factor (IRF)-1 is a transcription factor involved in inflammation.

Purpose of the Study:

  • To investigate the role of IRF-1 in Th1 cell function in patients with ACS.
  • To explore the potential of IRF-1 as a therapeutic target in ACS.

Main Methods:

  • CD4+ T cells were isolated from patients with ACS (chest pain, stable angina, unstable angina, acute myocardial infarction).
  • mRNA and protein expression of IRF-1 were analyzed.
  • IRF-1 gene was silenced using small interfering RNA (siRNA) in CD4+ T cells to assess its effect on Th1 cell function.

Main Results:

  • IRF-1 expression was significantly increased in CD4+ T cells of ACS patients, correlating with Th1 cytokine profiles.
  • IRF-1 inhibition in CD4+ T cells from ACS patients reduced Th1 cell frequencies and cytokine expression.
  • IRF-1 was found to modulate Th1 differentiation by influencing IL-12 receptor beta1, establishing IL-12 responsiveness.

Conclusions:

  • IRF-1 inhibition significantly decreases Th1 cell function in ACS.
  • IRF-1 may be a novel participant in the progression of ACS.
  • Targeting IRF-1 could be a potential therapeutic strategy for ACS.
Abstract

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...